My Cart

Mini Cart

News and conferences

CRLAB acquires French giant in the hair sector

Cesare Ragazzi Laboratories continues the internationalization process

Cesare Ragazzi Laboratories, the company based in Zola Predosa pioneer of hair replacement and the well-being of the skin-hair system, acquires Norgil, French leading company in the hair sector.
Over 50 years of history, with headquarters based in Lille and more than 40 centers throughout the French territory, including owned stores and affiliates, Norgil is the first group in France for hair care and replacement, with significant turnover before Covid.

“With this acquisition, conducted with AdviCorp as financial adviser and with the collaboration of the law firm Hores-Avocats of Paris led by Blaise Guichon, we are consolidating our position on the European market, estimated at half a billion euros – comments Stefano Ospitali, CRLAB Chief Executive Officer -. Norgil was not a manufacturer, but a distributor; we will bring the excellence of our Made in Italy to France “.

CRLAB trichological prostheses are the emblem of the world-renowned Made in Italy, a winning mix of innovation, research and excellent craftsmanship: rigorously custom-made, they are completely handmade, with never treated virgin natural hair, grafted one by one on a patented skin-friendly base polymer. CRLAB developed also hair care products, including an innovative hair loss prevention patch, clinically tested and studied for the well-being of the skin-hair system.
The international expansion of the company, also by virtue of the remarkable development of the cancer project for chemotherapy patients, has been constant since 2011: 170 employees, 14 million turnover expected for 2022, over 30 centers throughout the country. The 40 French centers will add to those of Sao Paulo in Brazil and San Diego in California. In addition, CRLAB is present with more than 120 independent centers in over 25 countries.

“Covid – comments Ospitali – has not stopped us from an operational point of view, since we produce medical devices; on the contrary, it has opened up opportunities for expansion, like this one with Norgil. We want to keep growing and to approach new financial markets within the next two to three years”.

Search in the articles
Search in the articles
Latest News and conference